Ginsenoside Rg3 enhances the chemosensitivity of tumors to cisplatin by reducing the basal level of nuclear factor erythroid 2-related factor 2-mediated heme oxygenase-1/NAD(P)H quinone oxidoreductase-1 and prevents normal tissue damage by scavenging cisplatin-induced intracellular reactive oxygen species
2012 ◽
Vol 50
(7)
◽
pp. 2565-2574
◽
2020 ◽
Vol 19
(2)
◽
pp. 133-138
Keyword(s):
2019 ◽
Vol 23
(2)
◽
pp. 121
◽
Keyword(s):
2014 ◽
Vol 34
(2)
◽
pp. 145-152
◽
Keyword(s):
2006 ◽
Vol 13
(5)
◽
pp. 388-396
◽
2017 ◽
Vol 10
(4)
◽
pp. 357-362
◽